Related Experiment Video
Updated: Feb 4, 2026

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq
Published on: July 10, 2019
RNA sequencing (RNA-Seq) and its application in ovarian cancer
Jinglu Wang1, Dylan C Dean2, Francis J Hornicek2
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Abstract:
Despite the surgical and chemotherapeutic advances over the past few decades, ovarian cancer remains the leading cause of gynecological cancer-related mortality. The absence of biomarkers in early detection and the development of drug resistance are principal causes of treatment failure in ovarian cancer. Recent progress in RNA sequencing (RNA-Seq) with Next Generation Sequencing technology has expanded the understanding of the molecular pathogenesis of ovarian cancer. As compared to previous hybridization-based microarray and Sanger sequence-based methods, RNA-Seq provides multiple layers of resolutions and transcriptome complexity, with less background noise and a broader dynamic range of RNA expression. Beyond quantifying gene expression, the data generated by RNA-Seq accelerates the identification of alternatively spliced genes, fusion genes, mutations/SNPs, allele-specific expression, novel transcripts and non-coding RNAs. RNA-Seq has been successfully applied in ovarian cancer research for earlier detection, ascertaining pathological origin, and defining the aberrant genes and dysregulated molecular pathways across patient groups. This review outlines the distinct advantages of RNA-Seq compared to other transcriptomics methods and its recent applications in ovarian cancer.
Insights
RNA sequencing (RNA-Seq) offers advanced insights into ovarian cancer molecular pathogenesis, outperforming older methods for early detection and identifying drug resistance markers. This technology enhances understanding of gene expression and molecular pathways for improved ovarian cancer research.
Area of Science:
- Genomics and Molecular Biology
- Oncology
- Biotechnology
Background:
- Ovarian cancer is a leading cause of gynecological cancer mortality, with early detection biomarkers and drug resistance remaining significant challenges.
- Advances in RNA sequencing (RNA-Seq) using Next Generation Sequencing technology have significantly improved our understanding of ovarian cancer's molecular basis.
Purpose of the Study:
- To review the advantages of RNA sequencing (RNA-Seq) over traditional transcriptomics methods in ovarian cancer research.
- To highlight recent applications of RNA-Seq in understanding ovarian cancer's molecular pathogenesis, detection, and treatment resistance.
Main Methods:
- Comparative analysis of RNA sequencing (RNA-Seq) with hybridization-based microarray and Sanger sequencing.
- Review of studies utilizing RNA-Seq for gene expression quantification, alternative splicing, mutation identification, and novel transcript discovery in ovarian cancer.
Main Results:
- RNA-Seq provides higher resolution, greater transcriptome complexity, reduced background noise, and a broader dynamic range compared to older methods.
- RNA-Seq facilitates identification of alternatively spliced genes, fusion genes, mutations, allele-specific expression, novel transcripts, and non-coding RNAs.
- Applications in ovarian cancer include earlier detection, pathological origin determination, and defining aberrant genes and molecular pathways.
Conclusions:
- RNA sequencing (RNA-Seq) is a powerful tool for advancing ovarian cancer research due to its comprehensive data output and analytical capabilities.
- The adoption of RNA-Seq is crucial for overcoming challenges in early detection and drug resistance, paving the way for improved patient outcomes.
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Splicing
RNA Stability
RNA Editing
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

